Found 6 matching trials
Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia
PHASE1This is a randomized, open-label, phase IB/II clinical study to evaluate th...
Location
Institute of Hematology & Blood Diseases Hospital
Study of CM313 in Subject With IgA Nephropathy
PHASE2This study is divided into two parts (Part A and Part B). This study aims t...
Location
Peking University First Hospital
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
PHASE2To evaluate the efficacy and safety of CM313(SC) injection in systemic lupu...
Location
Peking Union Medical College Hospital
Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)
PHASE2This is a randomized, double-blind, placebo-controlled study evaluating the...
Status
Active Not Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.
PHASE1Pemphigus is characterized by the presence of IgG antibodies that lead to t...
Location
Multiple Locations
Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness
PHASE1This is a randomized, open-label, phase IB/II clinical study to evaluate th...
Location
Institute of Hematology & Blood Diseases Hospital